A Double-Blind, Randomized Clinical Trial of Niacinamide 4% versus Hydroquinone 4% in the Treatment of Melasma

@inproceedings{NavarreteSols2011ADR,
  title={A Double-Blind, Randomized Clinical Trial of Niacinamide 4% versus Hydroquinone 4% in the Treatment of Melasma},
  author={Josefina Navarrete-Sol{\'i}s and Juan Pablo Castanedo-C{\'a}zares and Bertha Torres-{\'A}lvarez and Cuauht{\'e}moc Oros-Ovalle and Cornelia Fuentes-Ahumada and Francisco Javier Gonz{\'a}lez and Juan David Mart{\'i}nez-Ram{\'i}rez and B Jonathan Moncada},
  booktitle={Dermatology research and practice},
  year={2011}
}
Background. Multiple modalities have been used in the treatment of melasma with variable success. Niacinamide has anti-inflammatory properties and is able to decrease the transfer of melanosomes. Objective. To evaluate the therapeutic effect of topical niacinamide versus hydroquinone (HQ) in melasma patients. Patients and Methods. Twenty-seven melasma patients were randomized to receive for eight weeks 4% niacinamide cream on one side of the face, and 4% HQ cream on the other. Sunscreen was… CONTINUE READING

Figures, Tables, and Topics from this paper.

Citations

Publications citing this paper.
SHOWING 1-10 OF 13 CITATIONS

Topically Applied Nicotinamide Inhibits Human Hair Follicle Growth Ex Vivo.

  • The Journal of investigative dermatology
  • 2017
VIEW 2 EXCERPTS
CITES RESULTS & METHODS

Melasma, Novel Treatment Modalities

VIEW 2 EXCERPTS
CITES BACKGROUND

References

Publications referenced by this paper.
SHOWING 1-10 OF 13 REFERENCES

Raman spectroscopy of in vivo cutaneous melanin.

  • Journal of biomedical optics
  • 2004
VIEW 2 EXCERPTS

Similar Papers

Loading similar papers…